Bioceres Crop Solutions Secures Patent Protection for HB4 Wheat in the U.S. Until 2042
Bioceres Crop Solutions (NASDAQ: BIOX) has received a Notice of Allowance from the USPTO for its first event-specific patent covering HB4 Wheat, securing protection until 2042. This is the first of four potential patents for HB4 Wheat in the United States.
HB4 wheat technology offers improved drought tolerance and enhanced weed management compared to conventional wheat. The technology has already received USDA approval for cultivation and FDA approval for food and feed use in the U.S., which is the fourth largest wheat producer with nearly 40 million acres harvested in the most recent marketing year.
The company will follow the U.S. Wheat Associates' biotechnology commercialization principles, including securing regulatory approvals in major export markets, establishing tolerance thresholds, providing trait detection tests, and implementing product stewardship. The commercial rollout will utilize a broad licensing approach.
Bioceres Crop Solutions (NASDAQ: BIOX) ha ricevuto un Avviso di Concessione dall'USPTO per il suo primo brevetto specifico per evento che copre HB4 Wheat, garantendo protezione fino al 2042. Questo è il primo di quattro potenziali brevetti per HB4 Wheat negli Stati Uniti.
La tecnologia del grano HB4 offre una maggiore tolleranza alla siccità e una gestione migliorata delle infestanti rispetto al grano convenzionale. La tecnologia ha già ricevuto l'approvazione del USDA per la coltivazione e l'approvazione della FDA per l'uso alimentare e zootecnico negli Stati Uniti, che è il quarto produttore di grano più grande con quasi 40 milioni di acri raccolti nell'ultimo anno di commercializzazione.
L'azienda seguirà i principi di commercializzazione della biotecnologia delle U.S. Wheat Associates, inclusa l'ottenimento delle approvazioni normative nei principali mercati di esportazione, l'istituzione di soglie di tolleranza, la fornitura di test di rilevamento delle caratteristiche e l'implementazione della gestione del prodotto. Il lancio commerciale utilizzerà un ampio approccio di licenza.
Bioceres Crop Solutions (NASDAQ: BIOX) ha recibido un Aviso de Concesión de la USPTO para su primera patente específica de evento que cubre HB4 Wheat, asegurando protección hasta 2042. Este es el primero de cuatro posibles patentes para HB4 Wheat en los Estados Unidos.
La tecnología del trigo HB4 ofrece una mejor tolerancia a la sequía y una gestión de malezas mejorada en comparación con el trigo convencional. La tecnología ya ha recibido la aprobación del USDA para cultivo y la aprobación de la FDA para uso alimentario y de piensos en EE. UU., que es el cuarto mayor productor de trigo con casi 40 millones de acres cosechados en el año de comercialización más reciente.
La empresa seguirá los principios de comercialización de biotecnología de U.S. Wheat Associates, incluidos la obtención de aprobaciones regulatorias en los principales mercados de exportación, el establecimiento de umbrales de tolerancia, la provisión de pruebas de detección de rasgos y la implementación de la gestión del producto. El lanzamiento comercial utilizará un enfoque amplio de licencias.
Bioceres Crop Solutions (NASDAQ: BIOX)는 HB4 Wheat에 대한 첫 번째 이벤트 특정 특허에 대해 USPTO로부터 허가 통지를 받았으며, 2042년까지 보호를 확보했습니다. 이는 미국에서 HB4 Wheat에 대한 네 가지 잠재적 특허 중 첫 번째입니다.
HB4 밀 기술은 기존 밀에 비해 향상된 가뭄 내성과 잡초 관리 기능을 제공합니다. 이 기술은 이미 미국에서 재배를 위한 USDA 승인과 식품 및 사료 사용을 위한 FDA 승인을 받았으며, 미국은 최근 마케팅 연도에 거의 4000만 에이커의 밀을 수확한 네 번째로 큰 밀 생산국입니다.
회사는 미국 밀 협회의 생명공학 상업화 원칙을 따를 것이며, 여기에는 주요 수출 시장에서 규제 승인을 확보하고, 내성 기준을 설정하고, 형질 검출 테스트를 제공하고, 제품 관리 구현이 포함됩니다. 상업적 출시에는 광범위한 라이센스 접근 방식이 사용될 것입니다.
Bioceres Crop Solutions (NASDAQ: BIOX) a reçu un Avis de Concession de l'USPTO pour son premier brevet spécifique à un événement couvrant HB4 Wheat, garantissant une protection jusqu'en 2042. C'est le premier de quatre brevets potentiels pour HB4 Wheat aux États-Unis.
La technologie du blé HB4 offre une meilleure tolérance à la sécheresse et une gestion améliorée des mauvaises herbes par rapport au blé conventionnel. La technologie a déjà reçu l'approbation du USDA pour la culture et l'approbation de la FDA pour l'utilisation alimentaire et animale aux États-Unis, qui est le quatrième plus grand producteur de blé avec près de 40 millions d'acres récoltés lors de la dernière année de commercialisation.
L'entreprise suivra les principes de commercialisation de la biotechnologie des U.S. Wheat Associates, y compris l'obtention des approbations réglementaires sur les principaux marchés d'exportation, l'établissement de seuils de tolérance, la fourniture de tests de détection des caractéristiques et la mise en œuvre de la gestion des produits. Le lancement commercial utilisera une approche de licence large.
Bioceres Crop Solutions (NASDAQ: BIOX) hat eine Mitteilung über die Genehmigung vom USPTO für ihr erstes ereignisspezifisches Patent erhalten, das HB4 Wheat abdeckt, und sichert sich so bis 2042 Schutz. Dies ist das erste von vier potenziellen Patenten für HB4 Wheat in den Vereinigten Staaten.
Die HB4-Weizen-Technologie bietet im Vergleich zu herkömmlichem Weizen eine verbesserte Trockenheitstoleranz und ein besseres Unkrautmanagement. Die Technologie hat bereits die Genehmigung des USDA für den Anbau und die Genehmigung der FDA für die Verwendung in Lebensmitteln und Futtermitteln in den USA erhalten, die der viertgrößte Weizenproduzent ist und im letzten Vermarktungsjahr fast 40 Millionen Acres geerntet hat.
Das Unternehmen wird die Prinzipien der Biotechnologie-Kommerzialisierung der U.S. Wheat Associates befolgen, einschließlich der Sicherstellung von regulatorischen Genehmigungen in wichtigen Exportmärkten, der Festlegung von Toleranzgrenzen, der Bereitstellung von Nachweisverfahren für Merkmale und der Umsetzung von Produktverantwortung. Der kommerzielle Rollout wird einen breiten Lizenzansatz nutzen.
- Patent protection secured until 2042 for HB4 Wheat technology
- Already obtained USDA cultivation approval and FDA food/feed use approval
- Access to U.S. market with 40 million wheat acres potential
- Three additional patent opportunities pending in the U.S.
- Commercial rollout timeline not specified
- Still requires regulatory approvals in major export markets
HB4 wheat offers improved tolerance to drought and enhanced weed management options compared to conventional wheat. The technology has already been approved by the USDA for cultivation and by the FDA for food and feed use in
In alignment with the company’s commitment to responsible commercialization, Bioceres Crop Solutions will adhere to the
The commercial rollout of HB4 wheat in the
About Bioceres Crop Solutions Corp.
Bioceres Crop Solutions Corp. (NASDAQ: BIOX) is a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change. To do this, Bioceres’ solutions create economic incentives for farmers and other stakeholders to adopt environmentally friendlier production practices. The Company has a unique biotech platform with high-impact, patented technologies for seeds and microbial ag-inputs, as well as next generation crop nutrition and protection solutions. Through its HB4 program, the Company is bringing digital solutions to support growers’ decisions and provide end-to-end traceability for production outputs. For more information, visit here.
Forward-looking statements
This communication includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as “forecast,” “intend,” “seek,” “target,” “anticipate,” “believe,” “expect,” “estimate,” “plan,” “outlook,” and “project” and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. Such forward-looking statements are based on management’s reasonable current assumptions, expectations, plans and forecasts regarding the Company’s current or future results and future business and economic conditions more generally. Such forward-looking statements involve risks, uncertainties and other factors, which may cause the actual results, levels of activity, performance or achievement of the Company to be materially different from any future results expressed or implied by such forward-looking statements, and there can be no assurance that actual results will not differ materially from management’s expectations or could affect the Company’s ability to achieve its strategic goals. The preceding list is not intended to be an exhaustive list of all of our forward-looking statements. Therefore, you should not rely on any of these forward-looking statements as predictions of future events. All forward-looking statements contained in this release are qualified in their entirety by this cautionary statement. Forward-looking statements speak only as of the date they are or were made, and the Company does not intend to update or otherwise revise the forward-looking statements to reflect events or circumstances after the date of this release or to reflect the occurrence of unanticipated events, except as required by law.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250305870031/en/
Bioceres Crop Solutions
Paula Savanti
Head of Investor Relations
investorrelations@biocerescrops.com
Source: Bioceres Crop Solutions Corp.
FAQ
When does Bioceres Crop Solutions' (BIOX) HB4 Wheat patent expire in the United States?
How many acres of wheat market potential does BIOX have access to in the U.S.?
What are the key advantages of BIOX's HB4 Wheat technology?
What regulatory approvals has BIOX secured for HB4 Wheat in the United States?
How many additional HB4 Wheat patents is BIOX pursuing in the United States?
